Know Cancer

or
forgot password

Pilot Trial of Telemedicine Evaluation for Stem Cell Transplant Patients


N/A
18 Years
74 Years
Open (Enrolling)
Both
Stem Cell Transplant Patients

Thank you

Trial Information

Pilot Trial of Telemedicine Evaluation for Stem Cell Transplant Patients


Inclusion Criteria:



- Patients who underwent or are planning to undergo a hematopoietic progenitor cell
transplantation for any disease.

- Participants must be able to read and understand English*

- Age over 18 years of age since this pilot trial is only being performed in the Adult
BMT Service Non-English speaking patients have been excluded in this pilot study
because we do not have the support for translation services at this time.
Additionally, the telemedicine instruments being used are not yet validated across
all languages.

Potential patients will be identified according to their medical condition, type and
complexity of stem cell transplant procedure performed, and distance from MSKCC.

The patients should:

1. minimal comorbidities,

2. be less than 75 years of age. These characteristics have been associated with good
understanding and acceptance of telemedicine in other pilot trials. These
characteristics will be assessed by the clinician.

Please note: Patients on other therapeutic protocols will be eligible for this protocol as
well.

Exclusion Criteria:

- Medically unstable patient as deemed by the treating team.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Determine patient & physician acceptance of a "virtual medical visit" as a substitute for a "face to face" in pts in different settings. This is assessed by analyzing answers to questions 7 & 8 of the Patient Satisfaction Survey. [Question #7: I would

Outcome Description:

Question #8: Overall, I was very satisfied with today's telemedicine session.]Physician acceptance will be analyzed looking at the answers to question 19 of the Physician/Nurse survey in which the physician or nurse investigator relates the quality of the telemedicine visit. [Question #19: How would you rate the quality of the Telehealth visit to assess the patient compared to an in-person office visit?]

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Sergio Giralt, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

11-022

NCT ID:

NCT01324427

Start Date:

March 2011

Completion Date:

March 2014

Related Keywords:

  • Stem Cell Transplant Patients
  • Telemedicine
  • Virtual Medical Visit
  • Quality of Life
  • 11-022

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital CenterSleepy Hollow, New York  10591
Memoral Sloan Kettering Cancer CenterBasking Ridge, New Jersey  
Memorial Sloan-Kettering Cancer Center @ SuffolkCommack, New York  11725